LifeArc Ventures
Venture capital firm based in London, UK
Cytospire Therapeutics raises £61m to advance pan-gamma delta T cell first-in-human trials. Read more
Maxion Therapeutics secures £56.4M to pioneer antibody therapies, tackling complex diseases and transforming the biotech landscape. Read more
Browse thousands of angel investors and VC firms ranked by latest investments.